Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Saroja Pharma Industries India Ltd
Industry : Trading
BSE Code
ISIN Demat
Book Value(
)
91651
INE0PCL01011
36.4172043
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
SAROJA
26.58
23.3
EPS(TTM)
Face Value(
)
Div & Yield %:
2.18
10
0
Back
Uflex Ltd
Kaiser Corporation Ltd - Board Meeting Intimation for Approving The Standalone/Consolidated Unaudited Financial Results Of The Company For The Quarter Ended June 30 2024
Aug 05,2024
Kaiser Corporation Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Standalone/Consolidated Unaudited Financial Results of the Company for the quarter ended June 30 2024